13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The pharmacodynamics of low and standard doses of ticagrelor in patients with end stage renal disease on hemodialysis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Patients with end-stage renal disease (ESRD) on maintenance hemodialysis (HD) respond poorly to clopidogrel. We assessed the utility of low-dose ticagrelor in ESRD patients on maintenance HD.

          Related collections

          Author and article information

          Journal
          Int. J. Cardiol.
          International journal of cardiology
          Elsevier BV
          1874-1754
          0167-5273
          Jul 01 2017
          : 238
          Affiliations
          [1 ] Division of Nephrology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University, Seoul, Republic of Korea.
          [2 ] Division of Cardiology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University, Seoul, Republic of Korea.
          [3 ] Division of Cardiology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University, Seoul, Republic of Korea. Electronic address: mylovekw@hanmail.net.
          [4 ] Division of Nephrology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University, Seoul, Republic of Korea. Electronic address: aprilhwan@naver.com.
          Article
          S0167-5273(17)31521-8
          10.1016/j.ijcard.2017.03.026
          28342632
          da8b564c-58cc-4146-a54b-fd9fb447edac
          History

          Clopidogrel,End stage renal disease,Hemodialysis,Platelet,Ticagrelor

          Comments

          Comment on this article